Regulators of colon cancer angiogenesis

Expert Opinion on Therapeutic Targets

Volumn 4, Issue 3, 2000, Pages 347-359

  Ahmad, Syed A ^a   Shaheen, Raymond M ^a   Liu, Wenbiao ^a   Jung, Young D ^a   Takahashi, Yutaka ^a   Akagi, Yoshito ^a   Reinmuth, Niels ^a   Fan, Fan ^a   Ellis, Lee M ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

angiogenesis; PD ECGF; thrombospondin; VEGF

Indexed keywords

EID: 0006681377     PISSN: 14728222     EISSN: 17447631     Source Type: Journal    
DOI: 10.1517/14728222.4.3.347     Document Type: Review

References (62)

1. ELLIS LM: Tumor angiogenesis. In: Surgical Research. Souba WW, Wilmore DW (Eds.), Academic Press, San Diego, CA, USA (2000) (In Press).
2. FOLKMAN J, TYLER, K: Tumor angiogenesis: its possible role in metastasis and invasion. In: Cancer Invasion and Metastasis: Biologic Mechanisms and Therapy. Day SB, Myers WPL, Stansly P, Gerattini S, Lewis MG (Eds.), Raven Press, New York, USA (1977):95-103.
3. FOLKMAN J: How is blood vessel growth regulated in normal and neoplastic tissue? GHA Clowes Memorial Award Lecture. Cancer Res. (1986) 46:467-473. (Pubitemid 16145386)
4. FOLKMAN J: What is the evidence that tumors are angiogenesis dependent? J. Natl. Cancer Inst. (1989) 82:4-6.
5. FIDLER IJ, ELLIS LM: The implications of angiogenesis to the biology and therapy of cancer metastasis. Cell (1994) 79:185-188. (Pubitemid 24324908)
6. BOUCK N: Tumor angiogenesis: the role of oncogenes and tumor suppressor genes. Cancer Cells (1990) 2:179-185. (Pubitemid 20297998)
7. HOLASH J, MAISONPIERRE PC, COMPTON D et al.: Vessel cooption, regression and growth in tumors mediated by angiopoietins and VEGF. Science (1999) 284:1994-1998. (Pubitemid 29309448)
8. TISCHER E, MITCHELL R, HARTMAN T et al.: The human gene for vascular endothelial growth factor. Multiple protein forms are encoded through alternate exon splicing. J. Biol. Chem. (1991) 266:11947-11954.
9. CHEUNG N, WONG MP, YUEN ST, LEUNG SY, CHUNG LP: Tissue-specific expression pattern of vascular endothelial growth factor isoforms in the malignant transformation of lung and colon. Hum. Pathol. (1998) 29:910-914. (Pubitemid 28422038)
10. ZEBROWSKI BK, LIU W, RAMIREZ K, AKAGI Y, MILLS G, ELLIS LM: Markedly Elevated Levels of Vascular Endothelial Growth Factor in Malignant Ascites. Ann. Surg. Oncol. (1999) 6(4):373-378. (Pubitemid 29260800)
11. VEIKKOLA T, KARKKAINEN M, CLAESSON-WELSH L, ALITALO K: Regulation of angiogenesis via vascular endothelial growth factor receptors. Cancer Res. (2000) 60:203-212. (Pubitemid 30070735)
12. TAKAHASHI Y, KITADAI Y, BUCANA CD, CLEARY KR, ELLIS LM: Expression of vascular endothelial growth factor and its receptor, KDR, correlates with vascularity, metastasis and proliferation of human colon cancer. Cancer Res. (1995) 55:3964-3968.
13. WONG MP, CHEUNG N, YUEN ST, LEUNG SY, CHUNG LP: Vascular endothelial growth factor is up-regulated in the early pre-malignant stage of colorectal tumor progression. Int. J. Cancer (1999) 81:845-850. (Pubitemid 29249965)
14. BROWN LF, BERSE B, JACKMAN RW et al.: Expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in adenocarcinomas of the gastrointestinal tract. Cancer Res. (1993) 53:4727-4735. (Pubitemid 23304407)
15. TAKAHASHI Y, KITADAI Y, BUCANA CD, CLEARY KR, ELLIS LM: Expression of vascular endothelial growth factor and its receptor, KDR, correlates with vascularity, metastasis and proliferation of human colon cancer. Cancer Res. (1995) 55:3964-3968.
16. TAKAHASHI Y, TUCKER SL, KITADAI Y et al.: Vessel counts and expression of vascular endothelial growth factor as prognostic factor in node-negative colon cancer. Arch. Surg. (1997) 132:541-546. (Pubitemid 27215097)
17. ISHIGAMI SI, ARII S, FURUTANI MET AL.: Predictive value of vascular endothelial growth factor (VEGF) in metastases and prognosis of human colorectal cancer. Br. J. Cancer (1998) 78:1379-1384. (Pubitemid 28495254)
18. KANG SM, MAEDA K, ONODA N et al.: Combined analysis of p53 and vascular endothelial growth factor expression in colorectal carcinoma for determination of tumor vascularity and liver metastases. Int. J. Cancer (1997) 74:502-507. (Pubitemid 27486506)
19. TOKUNAGA T, OSHIKA Y, ABE Y et al.: Vascular endothelial growth factor (VEGF) mRNA isoform expression pattern is correlated with liver metastasis and poor prognosis in colon cancer. Br. J. Cancer(1998) 77:998-1002. (Pubitemid 28101792)
20. ANDRE T, KOTELEVETS L, VAILLANT JC et al.: VEGF, VEGF-B, VEGF-C and their receptors KDR, flt-1 and flt-4 during the neoplastic progression of human colonic mucosa. Int. J. Cancer (2000) 86:174-181. (Pubitemid 30180811)
21. SHIRAISHI A, ISHIWATA T, SHOJI T, ASANO G: Expression of PCNA, basic fibroblast growth factor, FGF-receptor and vascular endothelial growth factor in adenomas and carcinomas of human colon. Acta Histochem. Cytochem. (1995) 28:21-29.
22. WONG MP, CHEUNG N, YUEN ST, LEUNG SY, CHUNG LP: Vascular endothelial growth factor is up-regulated in the early pre-malignant stage of colorectal tumor progression. Int. J. Cancer (1999) 81:845-850. (Pubitemid 29249965)
23. LEE J, CHOW N, WANG S, HUANG S: Prognostic value of vascular endothelial growth factor expression in colorectal cancer patients. Eur. J. Cancer (2000) 36:748-753. (Pubitemid 30179746)
24. LEVY AP, LEVY NS, WEGNER S, GOLDBERG MA: Transcriptional regulation of the rat vascular endothelial growth factor gene by hypoxia. J. Biol. Chem. (1995) 270:13333-13340.
25. SHWEIKI D, NEEMAN M, ITIN A, KESHET E: Induction of vascular endothelial growth factor expression by hypoxia and by glucose deficiency in multicell spheroids: implications for tumor angiogenesis. Proc. Natl. Acad. Sci. USA (1995) 92:768-772.
26. SHWEIKI D, ITIN A, STOFFER D, KESHET E. Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature (1992) 359:843-845.
27. MUKHOPADHYAY D, TSIOKAS L, ZHOU XM, FOSTER D, BRUGGE JS, SUKHATME VP: Hypoxic induction of human vascular endothelial growth factor expression through c-src activation. Nature (1995) 375:577-581.
28. ELLIS LM, STALEY CA, LIU W et al.: Down-regulation of vascular endothelial growth factor in a human colon carcinoma cell line transfected with an antisense expression vector specific for c-src. J. Biol. Chem. (1998) 273:1052-1057. (Pubitemid 28049203)
29. AKAGI Y, LIU W, XIE K, ZEBROWSKI B, ELLIS LM: Regulation of vascular endothelial growth factor expression in human colon cancer by insulin-like growth factor-I. Cancer Res. (1998) 58:4008-4014. (Pubitemid 28405661)
30. AKAGI Y, LIU W, XIE K, ZEBROWSKI B, SHAHEEN RM, ELLIS LM: Regulation of vascular endothelial growth factor expression in human colon cancer by interleukin-1-beta. Br. J. Cancer (1999) 80:1506-1511. (Pubitemid 29308627)
31. TSAI JC, GOLDMAN CK, GILLESPIE GY: Vascular endothelial growth factor in human glioma cell lines: induced secretion by EGF, PDGF-BB and bFGF. J. Neurosurg. (1995) 82:864-873.
32. MAZURE NM, CHEN EY, LADEROUTE KR, GIACCIA AJ: Induction of vascular endothelial growth factor by hypoxia is modulated by a phosphatidylinositol 3-kinase/Akt signaling pathway in Ha-rastransformed cells through a hypoxia inducible factor-1 transcriptional element. Blood (1997) 90:3322-3331. (Pubitemid 27473400)
33. MAXWELL PH, DACHS GU, GLEADLE JM et al.: Hypoxiainducible factor-1 modulates gene expression in solid tumors and influences both angiogenesis and tumor growth. Proc. Natl. Acad. Sci. USA (1997) 94:8104-8109. (Pubitemid 27343784)
34. JUNG YD, NAKANO K, LIU W, GALLICK GE, ELLIS LM: Extracellular signal-regulated kinase activation is required for upregulation of vascular endothelial growth factor by serum starvation in human colon carcinoma cells. Cancer Res. (1999) 59:4804-4807. (Pubitemid 29472880)
35. RAK J, MITSUHASHI Y, BAYKO L et al.: Mutant ras oncogenes upregulate VEGF/VPF expression: implications for induction and inhibition of tumor angiogenesis. Cancer Res. (1995) 55:4575-4580.
36. BOUVET M, ELLIS LM, NISHIZAKI M et al.: Adenovirally mediated wild-type p53 gene transfer down-regulates vascular endothelial growth factor expression and inhibits angiogenesis in human colon cancer. Cancer Res. (1998) 58:2288-2292. (Pubitemid 28252680)
37. TAKAHASHI Y, BUCANA CD, CLEARY KR, ELLIS LM: p53, vessel count and vascular endothelial growth factor expression in human colon cancer. Int. J. Cancer (1998) 79:34-38. (Pubitemid 28157723)
38. WARREN RS, YUAN H, MATLI MR, GILLETT NA, FERRARA N: Regulation by vascular endothelial growth factor of human colon cancer tumorigenesis in a mouse model of experimental liver metastasis. J. Clin. Invest. (1995) 95:1789-1797.
39. FONG TT, SAWVER LK, SUN L et al.: SU5416 is a potent and selective inhibitor of the vascular endothelial growth factor receptor (flk-1/KDR) that inhibits tyrosine kinase catalysis, tumor vascularization and growth of multiple tumor types. Cancer Res. (1999) 59:99-106. (Pubitemid 29062964)
40. SHAHEEN RM, DAVIS DW, LIU W et al.: Antiangiogenic therapy targeting the tyrosine kinase receptor for vascular endothelial growth factor receptor inhibits the growth of colon cancer liver metastasis and induces tumor and endothelial cell apoptosis. Cancer Res. (1999) 59:5412-5416. (Pubitemid 29526446)
41. BRUNS CJ, LIU W, SHAHEEN R et al.: Vascular endothelial growth factor is an in vivo survival factor for tumor endothelium in a murine model of colorectal liver metastases. Cancer (2000) (In Press).
42. ISHIKAWA F, MIYAZONA K, HELLMAN U et al.: Identification of angiogenic activity and the cloning and expression of platelet-derived endothelial cell growth factor. Nature (1989) 338:557-562. (Pubitemid 19102308)
43. TAKAHASHI Y, BUCANA CD, AKAGI Y et al.: Significance of platelet-derived endothelial cell growth factor in the angiogenesis of human gastric cancer. Clin. Cancer Res. (1998) 4:429-434. (Pubitemid 28122759)
44. AMAYA H, TANIGAWA N, LU C et al.: Association of vascular endothelial growth factor expression with tumor angiogenesis, survival and thymidine phosphorylase/platelet-derived endothelial cell growth factor expression in human colorectal cancer. Cancer Lett. (1997) 119:227-235. (Pubitemid 27478108)
45. MATSURA T, KURATATE I, TERAMACHI K, OSAKI M, FUKUDA Y, ITO H: Thymidine phosphorylase expression is associated with both increase of intratumoral microvessels and decrease of apoptosis in human colorectal carcinomas. Cancer Res. (1999) 59:5037-5040. (Pubitemid 29472912)
46. SHOMORI K, SAKATANI T, GOTO A, MATSUURA T, KIYONARI H, ITO H: Thymidine phosphorylase expression in human colorectal mucosa, adenoma and carcinoma: role of p53 expression. Pathol. Int. (1999) 49:491-499. (Pubitemid 29411163)
47. MIYADERA K, SUMIZAWA T, HARAGUCHI MN et al.: Role of thymidine phosphorylase activity in the angiogenic effect of platelet-derived endothelial cell growth factor/thymidine phosphorylase. Cancer Res. (1995) 55:1687-1690.
48. FURUKAWA T, YOSHIMURA A, SUMIZAWA T et al.: Angiogenic factor. Nature (1992) 356:668.
49. BAEZINGER NL, BRODIE GN, MAJERUS PW: Isolation and properties of a thrombin-sensitive protein of human platelets. J. Biol. Chem. (1972) 247:2723-2731.
50. SAGE EH, BORNSTEIN P: Extracellular proteins that modulate cell-matrix interactions. J. Biol. Chem. (1991) 266:14831-14834. (Pubitemid 21907577)
51. QIAN X, TUSZYNSKI GP: Expression of thrombospondin-1 in cancer: a role in tumor progression. Proc. Soc. Exp. Biol. Med. (1996) 212:199-207.
52. ZABRENETSKY V, HARRIS CC, STEEG PS, ROBERTS DD: Expression of the extracellular matrix molecule thrombospondin inversely correlates with malignant progression in melanoma, lung and breast carcinoma cell lines. Int. J. Cancer (1994) 59:191-195. (Pubitemid 24343361)
53. TOKUNAGA T, NAKAMURA M, OSHIKA Y et al.: Thrombospondin 2 expression is correlated with inhibition of angiogenesis and metastasis of colon cancer. Br. J. Cancer (1999) 79:354-359. (Pubitemid 29002307)
54. TOKUNAGA T, NAKAMURA M, OSHIKA Y et al.: Alterations in tumor suppressor gene p53 correlate with inhibition of thrombospondin-1 gene expression in colon cancer cells. Virchows Arch. (1998) 433:415-418. (Pubitemid 28522029)
55. TSUCHIDA T, KIJIMA H, TOKUNAGA T et al.: Expression of the thrombospondin 1 receptor CD36 is correlated with decreased stromal vascularisation in colon cancer. Int. J. Oncol. (1999) 14:47-51.
56. NICOSIA RF, TUSZYNSKI GP: Matrix-bound thrombospondin promotes angiogenesis in vitro. J. Cell Biol. (1994) 124:183-193. (Pubitemid 24054620)
57. TARABOLETTI G, ROBERTS DD, LIOTTA LA, GIAVAZZI R: Platelet thrombospondin modulates endothelial cell adhesion, motility and growth: a potential angiogenesis regulatory factor. J. Cell Biol. (1990) 111:765-772.
58. BECKNER ME: Factors promoting tumor angiogenesis. Cancer Invest. (1999) 17:594-623.
59. CHODAK GW, HOSPELHORN V, JUDGE SM: Increased levels of fibroblast growth factor-like activity in urine from patients with bladder or kidney cancer. Cancer Res. (1988) 48:2083-2088.
60. LANDRISCINA M, CASSANO A, RATTO C et al.: Quantitative analysis of basic fibroblast growth factor and vascular endothelial growth factor in human colorectal cancer. Br. J. Cancer (1998) 78:765-770. (Pubitemid 28418310)
61. SHIMOYAMA S, YAMASAKI K, KAWAHARA M, KAMINISHI M: Increased serum angiogenin concentration in colorectal cancer is correlated with cancer progression. Clin. Cancer Res. (1999) 5:1125-1130. (Pubitemid 29233228)
62. PASQUALINI R, RUOSLAHTI E: Organ targeting in vivo using phage display peptide libraries. Nature (1996) 380:364-366. (Pubitemid 26097120)